The first new tuberculosis vaccine in a century is heading for mass production. India’s Serum Institute will manufacture M72/AS01E under an agreement with the Gates Medical Research Institute, investing more than $100 million ahead of approval. TB still kills 1.23 million people a year. WHO estimates a vaccine with this efficacy profile could prevent 76 million cases and save 8.5 million lives over 25 years. Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/indias-serum-institute-partners-with-gates-mri-make-expiremental-tb-vaccine-2026-07-16/
#ShareGoodNewsToo
Ada Palmer
npub1mw…47kde
2026-08-16 17:02:02 UTC
Author Public Key
npub1mwqat3n6zrwcevkrat8tqs370d5jxxmzfl9ktvcudndz0hwhd5psy47kdeSeen on
wss://relay.ditto.pubPublished at
2026-08-16 17:02:02 UTCEvent JSON
{
"id": "9acd4c784362934dc1dace689063f88481a4350dc9f9a706c6959220583972a9",
"pubkey": "db81d5c67a10dd8cb2c3eaceb0423e7b69231b624fcb65b31c6cda27ddd76d03",
"created_at": 1786899722,
"kind": 1,
"tags": [
[
"t",
"sharegoodnewstoo"
],
[
"proxy",
"https://wandering.shop/users/adapalmer/statuses/117106260180927505",
"activitypub"
],
[
"client",
"Mostr",
"31990:6be38f8c63df7dbf84db7ec4a6e6fbbd8d19dca3b980efad18585c46f04b26f9:mostr",
"wss://relay.ditto.pub"
]
],
"content": "The first new tuberculosis vaccine in a century is heading for mass production. India’s Serum Institute will manufacture M72/AS01E under an agreement with the Gates Medical Research Institute, investing more than $100 million ahead of approval. TB still kills 1.23 million people a year. WHO estimates a vaccine with this efficacy profile could prevent 76 million cases and save 8.5 million lives over 25 years. Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/indias-serum-institute-partners-with-gates-mri-make-expiremental-tb-vaccine-2026-07-16/\n#ShareGoodNewsToo",
"sig": "d8bed004ec438e260224935c1711094d1585b76d1a8999c620d2cccebaca79ec956cad4216d7dc107eaa736eadf04b9f4791cef9068abd200af69b54853d0c25"
}